Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by CaneIsAbelon Mar 09, 2024 11:43pm
93 Views
Post# 35924919

TLRY

TLRY

Stock Market News: Dow Closes Up 170 Points

The Nasdaq is on a four-day winning streak. Bitcoin's price is volatile ahead of ETF decision.

Last Updated: 

Jan. 10, 2024 at 7:32 PM EST

Live Coverage Feed

2 months ago

Tilray Sees Cannabis Rescheduling as Gateway to U.S. Medical Market

Tilray's EU campus in Portugal successfully harvests medical cannabis.

Tilray's EU campus in Portugal successfully harvests medical cannabis. (Courtesy of Tilray)

Tilray Brands believes it can get into the medical marijuana business in the U.S. pretty quickly if the Biden administration reclassifies cannabis as a Schedule 3 drug sometime this year, CEO Irwin Simon tells WSJ.

As one of the largest medical cannabis businesses in both Canada and Europe, Tilray has "the expertise in growth, the research and the know-how" to launch medical cannabis operations in the U.S. expeditiously, whether through a greenfield approach or by acquiring an existing player in the States, Simon says.

The CEO says Tilray would target the big markets on both coasts, including California and New York.


<< Previous
Bullboard Posts
Next >>